Predict your next investment

Academic/University
CONSUMER PRODUCTS & SERVICES | Education & Training (non-internet/mobile) / Colleges & Universities
unav.edu

See what CB Insights has to offer

Investments

1

Partners & Customers

1

About University of Navarra

University of Navarra is a private research university. Its mission is to seek and convey the truth, contribute to the academic, cultural, and personal growth of its students, provide appropriate development opportunities to its faculty and staff, and broadly cultural extension work and social development, with a clear purpose of service.

University of Navarra Headquarter Location

Campus Universitario

Pamplona, 31009,

Spain

+34 948 42 56 14

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

University of Navarra Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

University of Navarra Rank

Latest University of Navarra News

Hyfe’s smartphone cough-tracking app used in a groundbreaking epidemiological research

Aug 26, 2021

Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team of scientists and public health professionals, recently announced that their technology is now being incorporated into groundbreaking research in Spain in partnership with the University of Navarra, and involving over 800 participants. The inclusion of cough monitoring technology into community health research marks a significant step forward in the study of respiratory illnesses such as COVID-19 and others. The study will introduce artificial intelligence technology and cough detection smartphone applications into epidemiological research for the first time. This methodology of digital cough monitoring for early detection of respiratory disease outbreaks at a community level has never been performed in research settings before, either in Spain or throughout the world. The trial is taking place in the city of Pamplona, Spain and the neighboring municipalities of Cendea de Cizur and Zizur Mayor. Over 800 participants were selected through the Zizur health center and the University of Navarra who have consented to take part in the study. Participants are monitoring their nighttime cough patterns using the Hyfe smartphone app. Hyfe’s partnership with the University of Navarra, Zizur’s Health Center and Montreal University Hospital Center (CHUM) is centered around identifying if the digital study of cough monitoring can predict the incidence of respiratory diseases and potentially, the appearance of future outbreaks. Hyfe is an artificial intelligence platform that detects and tracks coughs as they happen in real-time via a smartphone or wearable device. The company’s advanced software platform encompasses machine learning algorithms to accurately detect cough and cough frequency in a precise fashion, before using acoustic analysis to help detect and diagnose respiratory illnesses. The company’s analytical recording for cough detection was first used in the study’s preliminary trial in October 2020. During this time, nearly 700,000 putative cough sounds were registered from participants, of which over 100,000 were classified by human observers, revealing a sensitivity of 96.34 percent and a specificity of 96.54 percent. Since the study began in late 2020, Hyfe’s technology has already helped patients identify several respiratory conditions resulting in an improvement to the quality of their lives. Related Stories All participants taking part in the research trial fully consented to have their medical data reviewed periodically throughout the course of the trial. From this regular analysis, the incidence of respiratory or cough-associated diseases can be established such as COVID-19, influenza, asthma, chronic obstructive pulmonary disease, gastro-oesophageal reflux disease, among others. Specifically, for the SARS-CoV-2 virus, daily incidence figures for the local area (Cendea de Cizur, Zizur Mayor, and Pamplona) will also be obtained from local health authorities. Data will be aggregated and used to build local epidemic curves of respiratory diseases during the study period to see if they correlate with registered changes in cough frequency According to WHO statistics, respiratory diseases are among the leading causes of death and disability in the world, with figures revealing around 334 million people suffer from asthma worldwide. Hyfe aims to use its technology to help curb the further spread of COVID-19 and identify signs of long COVID, as 191 million cases of coronavirus have been confirmed globally. When it comes to AI and healthcare, a joint report published by the European Union’s EIT and Mckinsey states that artificial intelligence tools can enable healthcare systems to provide better care to more people. Furthermore, AI can help improve the experience of healthcare practitioners, enabling them to spend more time on indirect patient care, therefore reducing burnout. Commenting on the significance of Hyfe’s use in respiratory clinical trial research, Hyfe Co-Founder and CEO Joe Brew said: “Covid-19 has taught us that the old way of doing epidemic surveillance and monitoring is simply not good enough. For health systems to effectively stay ahead of rapidly changing realities, both at the patient level as well as the population level, we need to enlist novel methods, novel sensors, and novel approaches. The trial in Navarra is the first ever to implement the concept of “acoustic syndromic surveillance” in real-world settings. I’m confident we’ll look back on this as a pivotal moment in global health history.” Source:

University of Navarra Investments

1 Investments

University of Navarra has made 1 investments. Their latest investment was in Nucaps Nanotechnology as part of their Seed VC on March 3, 2020.

CBI Logo

University of Navarra Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/23/2020

Seed VC

Nucaps Nanotechnology

$0.43M

Yes

1

Date

3/23/2020

Round

Seed VC

Company

Nucaps Nanotechnology

Amount

$0.43M

New?

Yes

Co-Investors

Sources

1

University of Navarra Acquisitions

1 Acquisition

University of Navarra acquired 1 company. Their latest acquisition was Predichteon on .

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

$1.02M

Spinoff / Spinout

1

Date

Investment Stage

Companies

Valuation

Total Funding

$1.02M

Note

Spinoff / Spinout

Sources

1

University of Navarra Partners & Customers

1 Partners and customers

University of Navarra has 1 strategic partners and customers. University of Navarra recently partnered with Vivet Therapeutics on May 5, 2017.

Date

Type

Business Partner

Country

News Snippet

Sources

5/4/2017

Partner

Vivet Therapeutics

France

Vivet Therapeutics raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseases

Vivet Therapeutics is building its pipeline based on novel technology developed through its partnerships with , and exclusive licenses from , the Fundación para la Investigación Médica Aplicada , a not-for-profit foundation at the Centro de Investigación Medica Aplicada , University of Navarra based in Pamplona , Spain ; and Massachusetts Eye and Ear , Boston , USA .

2

Date

5/4/2017

Type

Partner

Business Partner

Vivet Therapeutics

Country

France

News Snippet

Vivet Therapeutics raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseases

Vivet Therapeutics is building its pipeline based on novel technology developed through its partnerships with , and exclusive licenses from , the Fundación para la Investigación Médica Aplicada , a not-for-profit foundation at the Centro de Investigación Medica Aplicada , University of Navarra based in Pamplona , Spain ; and Massachusetts Eye and Ear , Boston , USA .

Sources

2

University of Navarra Team

3 Team Members

University of Navarra has 3 team members, including current Chief Executive Officer, Oscar Matellanes.

Name

Work History

Title

Status

Gabriel Gastaminza Lasarte

Founder

Current

Oscar Matellanes

Chief Executive Officer

Current

Gustavo P.

Managing Director

Current

Name

Gabriel Gastaminza Lasarte

Oscar Matellanes

Gustavo P.

Work History

Title

Founder

Chief Executive Officer

Managing Director

Status

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.